"10.1371_journal.pmed.1001796","plos medicine","2015-03-03T00:00:00Z","Ana-Carolina Martinez-Torres; Claire Quiney; Tarik Attout; Heloïse Boullet; Linda Herbi; Laura Vela; Sandrine Barbier; Danielle Chateau; Elise Chapiro; Florence Nguyen-Khac; Frédéric Davi; Magali Le Garff-Tavernier; Roba Moumné; Marika Sarfati; Philippe Karoyan; Hélène Merle-Béral; Pierre Launay; Santos A Susin","Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, INSERM UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Sorbonne Universités, Université Pierre et Marie Curie Paris 6, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; INSERM U1149, Paris, France; Faculté de Médecine, Site Xavier Bichat, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Laboratoire des Biomolécules, UMR 7203 and FR 2769, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; Centre National de la Recherche Scientifique, UMR 7203, Paris, France; Département de Chimie, École Normale Supérieure, Paris, France; Intestine: Nutrition, Barrier, and Diseases Team, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Service dHématologie Biologique, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique—Hôpitaux de Paris, Paris, France; Immunoregulation Laboratory, Centre de Recherche du Centre Hospitalier de lUniversité de Montréal, Montréal, Quebec, Canada","Conceived and designed the experiments: ACMT CQ TA LH LV SB DC PK HMB PL SAS. Performed the experiments: ACMT CQ TA HB LH LV SB DC PK. Analyzed the data: ACMT CQ TA HB LH LV SB DC MS PK HMB PL SAS. Contributed reagents/materials/analysis tools: HB EC FNK FD MLGT RM MS PK HMB SAS. Enrolled patients: FNK HMB. Peptide design: PK. Wrote the paper: ACMT MS PK HMB PL SAS. ICMJE criteria for authorship read and met: ACMT CQ TA HB LH LV SB DC EC FNK FD MLGT RM MS PK HMB PL SAS. Agree with manuscript results and conclusions: ACMT CQ TA HB LH LV SB DC EC FNK FD MLGT RM MS PK HMB PL SAS.","The patent applications PCT/EP2013/061727 and PCT/EP2014/077335 included results from this paper. The authors declare that no other competing interests exist.","2015","03","Ana-Carolina Martinez-Torres","ACMT",18,TRUE,11,9,13,6,TRUE,TRUE,FALSE,0,NA,FALSE
